7 h. ago Aja Health and Wellness Inc. Announces Update on Application for Management Cease Trade Order

Not for dissemination in the United States of America VANCOUVER, British Columbia, April 29, 2025 (GLOBE NEWSWIRE) — Aja Health and Wellness Inc. (“Aja” or the “Company”) (TSXV:Aja) announces that further to its April 17, 2025 news release, it has filed an amended application to the Alberta Securities Commission (the “ASC“) seeking a management cease […]

Economics

1 week ago Aja Health and Wellness Inc. Reports on Delay in Filing Annual Financial Statements

Not for dissemination in the United States of America VANCOUVER, British Columbia, April 17, 2025 (GLOBE NEWSWIRE) — Aja Health and Wellness Inc. (“Aja” or the “Company”) (TSXV:Aja) is announcing that it has completed the filing of an application seeking a management cease trade order (the “MCTO“) under National Policy 12-203- Management Cease Trade Orders, […]

Science

1 week ago Avicanna Announces Revocation of Management Cease Trade Order

TORONTO, April 16, 2025 (GLOBE NEWSWIRE) — Avicanna Inc. (“Avicanna” or “Company”) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a biopharmaceutical company focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-based products, is pleased to announce the Management Cease Trade Order (“MCTO”) issued on April 4, 2025 by the Ontario Securities Commission (“OSC”) has now […]

Economics

3 w. ago Avicanna Announces Receipt of Management Cease Trade Order and Provides Bi

Auditor Licensing & Personnel Issues Delays Issuance of Audit OpinionThe Company expects to file within 1 week TORONTO, April 07, 2025 (GLOBE NEWSWIRE) — Avicanna Inc. (“Avicanna” or “Company”) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a biopharmaceutical company focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-based products, that further to its March 31, […]

Economics

4 w. ago COSCIENS Biopharma Inc. Announces Receipt of Management Cease Trade Order

TORONTO, ONTARIO, April 01, 2025 (GLOBE NEWSWIRE) — COSCIENS Biopharma Inc. (NASDAQ: CSCI) (TSX: CSCI) (“COSCIENS” or the “Company”), a life science company which develops and commercializes a diversified portfolio of cosmeceutical, nutraceutical and pharmaceutical products, today announces further to its news release of March 19, 2025 (the “Default Announcement”) that its application to the […]

Economics

4 w. ago Avicanna Announces Late Filing of Financial Statements and Application for Management Cease Trade Order

Auditor Licensing & Personnel Issues Delays Issuance of Audit OpinionThe Company expects to file within 2 weeks TORONTO, March 31, 2025 (GLOBE NEWSWIRE) — Avicanna Inc. (“Avicanna” or “Company”) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a biopharmaceutical company focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-based products, announces that it will miss the […]

Economics